CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
0.3198
+0.0265 (9.04%)
At close: Apr 15, 2026, 4:00 PM EDT
0.3401
+0.0203 (6.35%)
After-hours: Apr 15, 2026, 4:23 PM EDT
CollPlant Biotechnologies Revenue
In the year 2025, CollPlant Biotechnologies had annual revenue of $2.37M with 360.39% growth. CollPlant Biotechnologies had revenue of $60.00K in the quarter ending December 31, 2025, a decrease of -63.41%.
Revenue (ttm)
$2.37M
Revenue Growth
+360.39%
P/S Ratio
1.78
Revenue / Employee
$60,795
Employees
39
Market Cap
4.61M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.37M | 1.86M | 360.39% |
| Dec 31, 2024 | 515.00K | -10.44M | -95.30% |
| Dec 31, 2023 | 10.96M | 10.66M | 3,565.22% |
| Dec 31, 2022 | 299.00K | -15.34M | -98.09% |
| Dec 31, 2021 | 15.64M | 9.50M | 154.86% |
| Dec 31, 2020 | 6.14M | 3.82M | 164.75% |
| Dec 31, 2019 | 2.32M | -2.70M | -53.77% |
| Dec 31, 2018 | 5.01M | 4.55M | 982.94% |
| Dec 31, 2017 | 463.00K | 387.12K | 510.15% |
| Dec 31, 2016 | 75.88K | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Moolec Science | 7.83M |
| Bio Green Med Solution | 747.00K |
| BioRestorative Therapies | 359.70K |
| Cardio Diagnostics Holdings | 14.83K |
| Aspire Biopharma Holdings | 6.20K |
| Ernexa Therapeutics | 1,000.00 |
CLGN News
- 2 days ago - CollPlant Issues Letter to Shareholders - PRNewsWire
- 20 days ago - COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - PRNewsWire
- 22 days ago - CollPlant Biotechnologies Receives Nasdaq Notification Regarding Minimum Bid Requirement - PRNewsWire
- 4 weeks ago - CollPlant Biotechnologies Launches Redesigned Corporate Website - PRNewsWire
- 5 weeks ago - COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FULL YEAR 2025 FINANCIAL RESULTS - PRNewsWire
- 6 weeks ago - CollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal Filler - PRNewsWire
- 7 weeks ago - CollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlex - PRNewsWire
- 2 months ago - CollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss Treatments - PRNewsWire